Liangfeng Zou
- Co-authors
- Jing‐Tao SunQi YinJian LiKun MengSongnan YangJiaojiao WangHai ZhuJunma Zhou
- Topics
- SARS-CoV-2 and COVID-19 Research (2 papers)RNA modifications and cancer (1 paper)Respiratory viral infections research (1 paper)
- Journals
- Journal of HepatologyEuropean Journal of ImmunologyJournal of Cellular and Molecular Medicine
- Partner nations
- ChinaMalaysiaUnited States
In The Last Decade
Liangfeng Zou
6 papers receiving 95 citations
Peers
Comparison fields: 5 of 43
- Molecular Biology 35
- Pharmacology 24
- Pathology and Forensic Medicine 17
- Ecology 17
- Cancer Research 15
Countries citing papers authored by Liangfeng Zou
This map shows the geographic impact of Liangfeng Zou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Liangfeng Zou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Liangfeng Zou more than expected).
Fields of papers citing papers by Liangfeng Zou
This network shows the impact of papers produced by Liangfeng Zou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Liangfeng Zou. The network helps show where Liangfeng Zou may publish in the future.
Co-authorship network of co-authors of Liangfeng Zou
This figure shows the co-authorship network connecting the top 25 collaborators of Liangfeng Zou. A scholar is included among the top collaborators of Liangfeng Zou based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Liangfeng Zou. Liangfeng Zou is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 1 | |
| 3 | 7 | |
| 4 | 5 | |
| 5 | 7 | |
| 6 | 50 | |
| 7 | 26 |
About Liangfeng Zou
Liangfeng Zou is a scholar working on Modeling and Simulation, Cancer Research and Hepatology, having authored 7 papers that have together received 96 indexed citations. Recurring topics across this work include SARS-CoV-2 and COVID-19 Research (2 papers), RNA modifications and cancer (1 paper) and Respiratory viral infections research (1 paper). The work is most often cited by research in Pharmacology (24 citations), Cancer Research (15 citations) and Pathology and Forensic Medicine (17 citations). Liangfeng Zou has collaborated with scholars based in China, Malaysia and United States. Frequent co-authors include Jing‐Tao Sun, Qi Yin, Jian Li, Kun Meng, Songnan Yang, Jiaojiao Wang, Hai Zhu, Junma Zhou, Jun Wang and Xueying Han. Their work appears in journals such as Journal of Hepatology, European Journal of Immunology and Journal of Cellular and Molecular Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.